Literature DB >> 17172726

Molecular classification of breast tumors: toward improved diagnostics and treatments.

Therese Sørlie1.   

Abstract

Recent advances in gene expression profiling and other "omics" technologies have revolutionized cancer research and hold the potential of also revolutionizing clinical practice. These high-throughout approaches have radically changed our ability to study cells and tissues in a more comprehensive way. Combined with advanced bioinformatics and the possibility to simulate biological processes in computers, this field of "systems biology" allows us to study the organism as a whole entity. This chapter describes the molecular classification and characterization of breast tumors into distinct subtypes by using DNA microarrays and discusses the statistical relationships of the subgroups with clinical features of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172726     DOI: 10.1385/1-59745-165-7:91

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

Review 1.  Biomarkers and surrogate end points--the challenge of statistical validation.

Authors:  Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

2.  What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2011-08-11       Impact factor: 8.775

3.  Breast cancer subtypes: morphologic and biologic characterization.

Authors:  Shahla Masood
Journal:  Womens Health (Lond)       Date:  2016-01-12

Review 4.  Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.

Authors:  Philippe L Bedard; Angelo Di Leo; Martine J Piccart-Gebhart
Journal:  Nat Rev Clin Oncol       Date:  2009-12-08       Impact factor: 66.675

Review 5.  Ethnic differences in breast cancer survival: status and determinants.

Authors:  Gertraud Maskarinec; Cherisse Sen; Karin Koga; Shannon M Conroy
Journal:  Womens Health (Lond)       Date:  2011-11

6.  Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.

Authors:  Rohit Bhargava; Joan Striebel; Sushil Beriwal; John C Flickinger; Agnieszka Onisko; Gretchen Ahrendt; David J Dabbs
Journal:  Int J Clin Exp Pathol       Date:  2009-02-09

7.  Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies.

Authors:  Jing Yu; Rohit Bhargava; David J Dabbs
Journal:  Diagn Pathol       Date:  2010-06-15       Impact factor: 2.644

8.  The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines.

Authors:  Kristina Subik; Jin-Feng Lee; Laurie Baxter; Tamera Strzepek; Dawn Costello; Patti Crowley; Lianping Xing; Mien-Chie Hung; Thomas Bonfiglio; David G Hicks; Ping Tang
Journal:  Breast Cancer (Auckl)       Date:  2010-05-20

9.  Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Authors:  Julio E Celis; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans-Wielenga; Fritz Rank; José M A Moreira
Journal:  Mol Oncol       Date:  2007-09-25       Impact factor: 6.603

10.  Expression of tight junction protein claudin-4 in basal-like breast carcinomas.

Authors:  Janina Kulka; Attila Marcell Szász; Zsuzsanna Németh; Lilla Madaras; Zsuzsa Schaff; István Arthur Molnár; Anna-Mária Tokés
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.